KE Spotlight
Filter
-
A Pioneer for Healthcare Reform in China
The HKU-Shenzhen Hospital was conceived as a model for modernising the management of the Mainland public hospital system. Five years since its establishment, the Hospital is well on its way to fulfilling its mission.
Read More -
Balancing Act
Balance impairment among the elderly often leads to serious issues such as falls, broken bones, and long convalescences in hospital. A new initiative of the School of Public Health hopes to improve the situation through dancing.
Read More -
Centre for Genomic Sciences and Department of Pharmacology and Pharmacy organise public lecture series "Genomic Medicine II: Precision Medicine"
The Centre for Genomic Sciences and the Department of Pharmacology and Pharmacy of the HKU Li Ka Shing Faculty of Medicine are organizing a series of six public lectures, "Genomic Medicine II: Precision Medicine", to enhance people's awareness, knowledge and interest on genomic medicine in Hong Kong. It will introduce the background of genomic medicine, the latest information and application of genomic medicines in various clinical conditions. The first lecture, "The 'Good' and 'Bad' Cholesterol" will be held on November 12.
Read More -
Knowledge Exchange Awards 2016
The annual Faculty Knowledge Exchange (KE) Awards recognize each Faculty's outstanding KE accomplishment that has made demonstrable economic, social or cultural impacts to benefit the community, business/industry, or partner organizations. The KE Award (Non-Faculty Unit) was introduced with the same objective for the independent centres, institutes and units of the University. Results of the 2016 KE Awards are now available.
Read More -
HKU Phase 1 Clinical Trials Centre receives clinical drug trial accreditation by the China Food and Drug Administration
The HKU Phase 1 Clinical Trials Centre, together with seven clinical specialties of Queen Mary Hospital, received official accreditation by the China Food and Drug Administration (CFDA) for conducting clinical drug trials. The HKU centre is a clinical research facility of the HKU Clinical Trials Centre (HKU-CTC), specifically designed for performing phase 1, early phase and clinical pharmacology trials. This accreditation signifies that research data and results arising from clinical trials conducted in the centre and the seven clinical specialties will be accepted by the CFDA for evaluation of applications for drug registration in Mainland China, strengthening Hong Kong's special position as a hub for drug research and development in China and worldwide.
Read More -
HKU to offer Zika screening to travellers returning from Rio de Janeiro Olympics
Ten public clinics under the Hospital Authority will increase capacity to provide consultation for Hong Kong delegates and travellers returning from Brazil. It is one of the government’s measures to prevent the spread of the Zika virus to Hong Kong when the Olympics and the Paralympics open in Rio de Janeiro. Thousands of Hongkongers - including athletes and supporting staff, tourists and the media - will visit Brazil in the coming two to three months. HKU microbiologist Professor Yuen Kwok-yung warned that around 80% of those infected with the disease could be silent carriers who never show symptoms. The Food and Health Bureau has commissioned HKU Department of Microbiologyto conduct tests for the virus for people returning from the Olympics without symptoms but felt worried about the risk of infection. HKU will offer them screening by taking urine and blood samples, with results expected in seven days.
Read More -
A Start-up with Backbone
The Department of Orthopaedics and Traumatology has developed new shape-shifting rods that offer a gentler option for correcting curvature of the spine. They now have a viable product and a start-up to support it, OrthoSmart Limited.
Read More